| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Repare Therapeutics Inc. | RPTX | Grant | Stock Option (right to buy) | 27.2k | $11.66 | $317.2k | | 06/08/2023 |
| 05/13/2022 | Repare Therapeutics Inc. | RPTX | Grant | Stock Option (right to buy) | 49k | $9.55 | $468k | | 05/13/2022 |
| 03/31/2022 | Pyxis Oncology, Inc. | PYXS | Grant | Common Stock | 66.8k | $0.00 | $0 | | 03/31/2022 |
| 11/18/2021 | Pyxis Oncology, Inc. | PYXS | Purchase | Common Stock | 15.7k | $12.74 | $200k | By Civik Family Trust | 11/18/2021 |
| 11/16/2021 | Repare Therapeutics Inc. | RPTX | Purchase | Common Shares | 7.5k | $28.08 | $210.6k | | 11/16/2021 |
| 10/07/2021 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to buy) | 42.2k | $16.00 | $675.1k | | 10/07/2021 |
| 09/07/2021 | Repare Therapeutics Inc. | RPTX | Grant | Stock Option (right to buy) | 42k | $33.89 | $1.4M | | 09/07/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Employee Stock Option (right to buy) | 480k | $2.72 | $1.3M | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Common Stock | 69k | $38.00 | $2.6M | | 04/16/2021 |
| 04/09/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 11.1k | $37.94 | $420.7k | | 04/09/2021 |
| 04/13/2020 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Employee Stock Option (right to buy) | 480k | $2.72 | $1.3M | | 04/13/2020 |
| 04/13/2020 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Common Stock | 75k | $0.00 | $0 | | 04/13/2020 |
| 07/31/2018 | Foundation Medicine, Inc. | FMI | Other (disposition) | Common Stock | 33.4k | $137.00 | $4.6M | | 07/31/2018 |
| 01/01/2018 | Foundation Medicine, Inc. | FMI | Grant | Common Stock | 33.4k | $68.20 | $2.3M | | 01/01/2018 |